blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4257150

EP4257150 - Subcutaneous anti-her2 antibody formulation [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  13.10.2023
Database last updated on 14.09.2024
FormerRequest for examination was made
Status updated on  08.09.2023
Most recent event   Tooltip24.07.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2023/41]
Inventor(s)01 / Adler, Michael
79540 Loerrach / DE
02 / Grauschopf, Ulla
4125 Riehen / CH
03 / Mahler, Hanns-Christian
79541 Loerrach / DE
04 / Stauch, Oliver Boris
89160 Dornstadt / DE
 [2023/41]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstraße 3
81675 München / DE
[2023/41]
Application number, filing date23172095.428.07.2010
[2023/41]
Priority number, dateEP2009016702531.07.2009         Original published format: EP 09167025
[2023/41]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4257150
Date:11.10.2023
Language:EN
[2023/41]
Type: A3 Search report 
No.:EP4257150
Date:01.11.2023
Language:EN
[2023/44]
Search report(s)(Supplementary) European search report - dispatched on:EP04.10.2023
ClassificationIPC:A61K9/00, A61K9/19, A61K38/47, A61K39/395, A61K47/18, A61K47/20, A61K47/26, A61K47/42, A61P35/00, A61P35/04, C07K16/32
[2023/44]
CPC:
A61K9/0019 (EP,IL,KR,US); A61K39/39558 (IL,US); A61K9/08 (IL,KR,US);
A61K38/47 (EP,IL,US); A61K39/39591 (EP,IL,KR,US); A61K45/06 (IL,US);
A61K47/18 (EP,IL,KR,US); A61K47/183 (EP,IL,KR,US); A61K47/20 (EP,IL,US);
A61K47/26 (EP,IL,KR,US); A61K47/42 (EP,IL,KR,US); A61K9/19 (EP,IL,KR,US);
A61P35/00 (EP,IL); A61P35/04 (EP,IL); C07K16/32 (EP,IL,KR,US);
C12Y302/01035 (EP,IL,US); A61K2121/00 (IL,KR) (-)
Former IPC [2023/41]A61K47/42
Designated contracting statesDK [2023/41]
Extension statesBA27.10.2023
RS27.10.2023
TitleGerman:Subkutane Anti-HER2-Antikörperformulierung[2023/41]
English:Subcutaneous anti-her2 antibody formulation[2023/41]
French:Formulation d'anticorps anti-her2 sous-cutané[2023/41]
Examination procedure28.07.2023Examination requested  [2023/41]
04.10.2023Date on which the examining division has become responsible
16.10.2023Despatch of a communication from the examining division (Time limit: M04)
27.10.2023Reply to a communication from the examining division
Parent application(s)   TooltipEP10737891.1  / EP2459167
EP13166031.8  / EP2687202
Divisional application(s)EP23206430.3  / EP4339212
Fees paidRenewal fee
08.06.2023Renewal fee patent year 03
08.06.2023Renewal fee patent year 04
08.06.2023Renewal fee patent year 05
08.06.2023Renewal fee patent year 06
08.06.2023Renewal fee patent year 07
08.06.2023Renewal fee patent year 08
08.06.2023Renewal fee patent year 09
08.06.2023Renewal fee patent year 10
08.06.2023Renewal fee patent year 11
08.06.2023Renewal fee patent year 12
08.06.2023Renewal fee patent year 13
20.07.2023Renewal fee patent year 14
23.07.2024Renewal fee patent year 15
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]US6267958  (ANDYA JAMES [US], et al);
 [A]US2002035736  (ERICKSON SHARON [US], et al);
 [A]WO2005023328  (BECTON DICKINSON CO [US], et al);
 [A]US2006088523  (ANDYA JAMES [US], et al);
 [A]US2006104968  (BOOKBINDER LOUIS H [US], et al);
 [A]US2007071675  (WU CHENGBIN [US], et al);
 [A]WO2008150949  (ABBOTT LAB [US], et al);
otherEP2459167
 EP2687202
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.